Counseling and guidence Center of the Department of education of region 9 of Tehran
Tehran, Tehran Province, Iran
NCT Number: NCT01675804
Current research aimed to compare the efficacy of computer-assisted cognitive rehabilitation (CACR), stimulant drugs and Placebo CACR on executive functions and clinical symptoms of children with attention deficit/hyperactivity disorder (ADHD).
Looking for future studies?
Notify Me7 year–12 year
Male
Interventional
Phase 3
Tehran, Tehran Province, Iran
The investigators administered a randomized controlled trial (RCT) through random assignment of ADHD subjects in to three different groups to compare the effects of CACR, immediate-release methylphenidate, and a Placebo CACR (i.e. some computerized tasks assumed not having any therapeutic effects) on the functioning of children with ADHD.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-drug therapy: 2 or 3 doses of 10 mg tablets of Immediate-release Methylphenidate (Ritalin) per day for 2 months.
Other names: Immediate release methylphenidate
PCACR: 20 ninety-minute sessions of Placebo computerized cognitive training.
Time frame: 5 months
The Persian software of CPT is a visual CPT test.
Time frame: 5 months
Persian TOL is a software version of tower of London test (TOL) which was developed in Iran.
Time frame: 5 months
Reversed digit span from the WISC-R (Wechsler, 1974) was used to measure executive verbal WM and the forward digit span was used to measure short-term memory.
Time frame: 5 months
Raven's colored progressive matrices (Raven, 1995) was used to measure complex non-verbal reasoning.
Time frame: 5 months
Time frame: 5 months
Allameh Tabatabai University
Other
A Randomized Clinical Trial Comparing Computer-assisted Cognitive Rehabilitation (CACR), Psycho-stimulants, and Placebo CACR in the Treatment of Attention Deficit/ Hyperactivity Disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01876524
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Cartagena, Murcia, Spain
View Trial DetailsNCT06679010
Anxiety, Anxiety Disorders
Odense, Denmark
View Trial DetailsNCT02364817
Alcohol-Related Disorders, Alcoholism
Bron, France
View Trial DetailsNCT07253441
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Lenexa, Kansas, United States
View Trial Details